Press Release

BV AND OPTEL LAUNCH
V-TRACE, A COMPLETE 
TRACEABILITY SOLUTION FOR COVID-19 VACCINES

Feb. 4 2021

Bureau Veritas and OPTEL join forces to address the critical issue of reliability and traceability in COVID-19 vaccine logistics chains.

In the next few months, billions of doses of COVID-19 vaccines will need to be rapidly and safely administered to people around the world. The complexity of cold chain conditions, the timeliness of delivery as well as the need to mitigate risk of any deviation are identified as critical challenges for successful large-scale vaccination.

V-TRACE is an integrated solution designed to track and trace COVID-19 vaccines, while ensuring risk mitigation thanks to controls and inspections all along the logistics chain. V-TRACE provides a global control of the supply chain thanks to the local presence of inspectors in the field.

Thanks to this partnership, OPTEL and Bureau Veritas are able to offer a combined expertise that is unrivalled in the pharmaceutical industry and in supply chain assurance.

V-TRACE is a unique integrated solution providing Governments with :

  • VISIBILITY to control their vaccine orders all along the logistics chain in one single control tower, ensuring the traceability of every batch of vaccines.
  • COMPLIANCE of vaccine batches through verified collected information on storage and distribution conditions all along the logistics chain.
  • ASSURANCE that their vaccines are well stored, transported and conserved, in particular assurance that cold chain requirements are met, with temperature verification performed by Bureau Veritas’ inspectors along the logistics chain.

DOWNLOAD THE PRESS RELEASE

MORE ABOUT OPTEL GROUP